Average Co-Inventor Count = 5.11
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Schering Corporation (18 from 1,829 patents)
2. Merck Sharp + Dohme Corp. (11 from 2,405 patents)
29 patents:
1. 9301929 - Substituted biaryl derivatives and methods of use thereof
2. 9161924 - Factor IXa inhibitors
3. 8907095 - Bicyclic heterocycle derivatives and their use as modulators of the activity of GPR119
4. 8822480 - Bicyclic heterocycle derivatives and use thereof as GPR119 modulators
5. 8815876 - Bicyclic heterocycle derivatives and methods of use thereof
6. 8604195 - Substituted bicyclic piperidinyl- and piperazinyl-sulfonamides useful to inhibit 11β-hydroxysteroid dehydrogenase type-1
7. 8580807 - Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders
8. 8466149 - 6-substituted sulfonyl azabicyclo[3.2.1]octanes useful to inhibit 11β-hydroxysteroid dehydrogenase type-I
9. RE44205 - Adenosine Areceptor antagonists
10. 8389532 - 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-E]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine
11. 8318751 - Pyrimidinone derivatives and methods of use thereof
12. 7709492 - [object Object]
13. 7572802 - 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7H-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-C]-pyrimidin-5-amine
14. 7531544 - Xanthine phosphodiesterase V inhibitors
15. 7465740 - 2-heteroaryl-pyrazolo-[4,3-e]-1,2,4-triazolo-[1,5-c]-pyrimidine adenosine A2a receptor antagonists